» Articles » PMID: 25984562

Theory of Partial Agonist Activity of Steroid Hormones

Overview
Journal AIMS Mol Sci
Specialty Biochemistry
Date 2015 May 19
PMID 25984562
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The different amounts of residual partial agonist activity (PAA) of antisteroids under assorted conditions have long been useful in clinical applications but remain largely unexplained. Not only does a given antagonist often afford unequal induction for multiple genes in the same cell but also the activity of the same antisteroid with the same gene changes with variations in concentration of numerous cofactors. Using glucocorticoid receptors as a model system, we have recently succeeded in constructing from first principles a theory that accurately describes how cofactors can modulate the ability of agonist steroids to regulate both gene induction and gene repression. We now extend this framework to the actions of antisteroids in gene induction. The theory shows why changes in PAA cannot be explained simply by differences in ligand affinity for receptor and requires action at a second step or site in the overall sequence of reactions. The theory also provides a method for locating the position of this second site, relative to a concentration limited step (CLS), which is a previously identified step in glucocorticoid-regulated transactivation that always occurs at the same position in the overall sequence of events of gene induction. Finally, the theory predicts that classes of antagonist ligands may be grouped on the basis of their maximal PAA with excess added cofactor and that the members of each class differ by how they act at the same step in the overall gene induction process. Thus, this theory now makes it possible to predict how different cofactors modulate antisteroid PAA, which should be invaluable in developing more selective antagonists.

Citing Articles

Dissecting transcriptional amplification by MYC.

Nie Z, Guo C, Das S, Chow C, Batchelor E, Simons Jnr S Elife. 2020; 9.

PMID: 32715994 PMC: 7384857. DOI: 10.7554/eLife.52483.


An Approach to Greater Specificity for Glucocorticoids.

Chow C, Simons Jr S Front Endocrinol (Lausanne). 2018; 9:76.

PMID: 29593646 PMC: 5859375. DOI: 10.3389/fendo.2018.00076.


Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction.

Pradhan M, Blackford Jr J, Devaiah B, Thompson P, Chow C, Singer D J Biol Chem. 2015; 291(1):342-54.

PMID: 26504077 PMC: 4697169. DOI: 10.1074/jbc.M115.683722.

References
1.
Sistare F, Hager G, Simons Jr S . Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: I. Receptor-antiglucocorticoid complexes do not competitively inhibit receptor-glucocorticoid complex activation of gene transcription in vivo. Mol Endocrinol. 1987; 1(9):648-58. DOI: 10.1210/mend-1-9-648. View

2.
Macgregor J, Jordan V . Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev. 1998; 50(2):151-96. View

3.
Cho S, Blackford Jr J, Simons Jr S . Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes. Biochemistry. 2005; 44(9):3547-61. DOI: 10.1021/bi048777i. View

4.
Wang Q, Blackford Jr J, Song L, Huang Y, Cho S, Simons Jr S . Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Mol Endocrinol. 2004; 18(6):1376-95. DOI: 10.1210/me.2003-0421. View

5.
Kaul S, Blackford Jr J, Cho S, Simons Jr S . Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors. J Biol Chem. 2002; 277(15):12541-9. DOI: 10.1074/jbc.M112330200. View